A 42-year-old man, who had taken part in the trial of indigenous coronavirus vaccine Covaxin in Bhopal on December 12, died nine days later, with doctors suspecting that poisoning could be the......
Pharma major Johnson & Johnson has said its COVID-19 vaccine study has been temporarily halted due to an unexplained illness in a trial participant. "We have temporarily paused further dosing in......
A volunteer in Brazil's clinical trial of COVID-19 vaccine being developed by AstraZeneca and Oxford University has died, the Brazilian health agency Anvisa announced, adding that the trial will......
Homeopathy is no more effective than placebos in treating health conditions that are chronic, serious, or could become serious, a major Australian study has found. The National Health and Medical......
The Drugs Controller General of India on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed COVID-19 vaccine with certain conditions, officials said.......
According to a 2011 impact assessment study of the programme by Banerjee and Duflo, along with economists Raghabendra Chattopadhyay and Jeremy Shapiro, Bandhan’s THP results in a 15 per cent......